Literature DB >> 23578777

Confirmed penicillin allergy among patients receiving benzathine penicillin prophylaxis for acute rheumatic fever.

A Kaya1, M Erkoçoğlu1, O G Senkon2, F K Ekici3, M Toyran1, I İ Çetin3, C N Kocabaş4.   

Abstract

BACKGROUND: Beta-lactam antibiotics are the most frequent drugs prescribed in children worldwide. Acute rheumatic fever (ARF) is the major cause of acquired heart disease among children and adolescents. Recurrences due to inadequate penicillin prophylaxis are responsible for chronic valvular lesions requiring surgery. The fear of a severe allergic reaction is the leading cause of discontinuing prophylaxis.
OBJECTIVE: In this study, we aimed to reveal the frequency of adverse events and real allergic reactions to benzathine penicillin among children who are followed in our paediatric cardiology clinic with a diagnosis of ARF. MATERIALS
METHODS: The children who were followed with a diagnosis of ARF between January 2005 and December 2011 were searched for a history of penicillin allergy. Patients with a positive history were evaluated in our paediatric allergy clinic. Skin tests and provocation tests were performed with parental consent.
RESULTS: In total 535 children with a diagnosis of ARF were analysed for the study. Median follow up period was 24 months (12-36) [median (%25-75)]. Eleven of our 535 (11/17.641 injection) ARF patients were suspected to have allergic reactions after 17.641 penicillin injections but only one (0.18%) was diagnosed to have penicillin allergy after detailed evaluation.
CONCLUSION: Our data suggest that the frequency of penicillin allergy is much lower than suspected among children on penicillin prophylaxis for ARF. Consequently, penicillin prophylaxis should not be given up without proper evaluation of drug allergy.
Copyright © 2012 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Acute rheumatic fever; Benzathine penicillin prophylaxis; Penicillin allergy

Mesh:

Substances:

Year:  2013        PMID: 23578777     DOI: 10.1016/j.aller.2012.12.007

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  4 in total

1.  Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.

Authors:  Sheron Boswell Thompson; Cerese Hepburn Brown; Ann Marie Edwards; Jascinth L M Lindo
Journal:  Pathog Glob Health       Date:  2014-08-11       Impact factor: 2.894

2.  Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis: cardiac compromise more likely than anaphylaxis.

Authors:  Shannon Marantelli; Robert Hand; Jonathan Carapetis; Andrea Beaton; Rosemary Wyber
Journal:  Heart Asia       Date:  2019-06-20

Review 3.  A programme to increase appropriate usage of benzathine penicillin for management of streptococcal pharyngitis and rheumatic heart disease in Zambia.

Authors:  Aidan Long; Joyce Chipili Lungu; Elizabeth Machila; Sherri Schwaninger; Jonathan Spector; Brigitta Tadmor; Mark Fishman; Bongani M Mayosi; John Musuku
Journal:  Cardiovasc J Afr       Date:  2017 Jul/Aug       Impact factor: 1.167

4.  Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association.

Authors:  Amy Sanyahumbi; Sulafa Ali; Ivor J Benjamin; Ganesan Karthikeyan; Emmy Okello; Craig A Sable; Kathryn Taubert; Rosemary Wyber; Liesl Zuhlke; Jonathan R Carapetis; Andrea Z Beaton
Journal:  J Am Heart Assoc       Date:  2022-01-20       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.